The Trump administration is doubling down on efforts to revamp the federal discount drug program — a major flashpoint between ...

Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials involved in ...

WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...

The Trump administration’s injection of political priorities into the agency, which has long been shielded from such meddling, has opened new avenues for lobbying.

Orthopedics was the most active area over the second half of calendar 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.

Sentante announced that its Sentante stroke system has been accepted into the FDA Total Product Life Cycle Advisory Program ...

Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...